These studies suggest that AFB1 may be involved in airway inflammation and remodeling in asthma through neuroactive ligand‒receptor interactions, calcium signaling pathways, adipocyte lipolysis, and the cGMP‒PKG signaling pathway, potentially contributing to asthma exacerbation. This evidence concerns the gene PRKG1 and asthma.